Study on Therapeutic Mechanism of Natural Psychotherapy for Neurosis
Launched by XIANG YANG ZHANG · May 29, 2024
Trial Information
Current as of February 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how effective a type of therapy called natural psychotherapy is for treating obsessive-compulsive disorder (OCD). The goal is to find objective signs that show whether this therapy helps people manage their symptoms better. The study is currently recruiting participants aged 15 to 60 who have been diagnosed with OCD or similar compulsive behaviors for at least a year. It's important to note that participants must be able to attend assessments in person in Beijing.
If you or someone you know is eligible, you can expect to take part in a structured program that looks into the effects of this therapy on your condition. However, individuals with certain physical health issues, like a history of stroke or brain injury, or those who struggle with substance abuse, will not be able to join. This trial aims to provide valuable insights into new treatment options for OCD, helping improve the lives of those affected by this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have a diagnosis of obsessive-compulsive disorder or compulsive behavior
- • Duration of symptoms for not less than 12 months
- • Age 15-60 years old.
- • You can participate in the whole experiment and offline assessment in Beijing
- Exclusion Criteria:
- • Documented disease of physical diseases including, but not limited to stroke, tumor, Parkinson's disease, Huntington's disease, seizure, epilepsy, history of brain trauma
- • Subjects who suffered from alcohol or illegal drug abuse/dependence
Trial Officials
Xiang-Yang Zhang, M.D., Ph.D
Principal Investigator
Institute of Psychology, Chinese Academy of Science
About Xiang Yang Zhang
Xiang Yang Zhang is a distinguished clinical trial sponsor with a robust portfolio in advancing innovative therapeutics across various medical fields. Committed to enhancing patient outcomes through rigorous research, Zhang's initiatives focus on the development and evaluation of novel treatment modalities. With a strong emphasis on scientific integrity and ethical standards, the sponsor collaborates with leading research institutions and healthcare professionals to ensure comprehensive clinical trial management, from design to execution. Their dedication to improving healthcare solutions positions them as a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hefei, Anhui, China
Beijing, , China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0